Zobrazeno 1 - 1
of 1
pro vyhledávání: '"Ragini R. Kudchadkar"'
Publikováno v:
Expert opinion on drug safety. 14(4)
Selective inhibition of the MAPK pathway with either BRAF or MEK inhibition has emerged as a key component for the treatment of BRAF-mutant metastatic melanoma. New evidence suggests that the combination of BRAF and MEK inhibitors improves tumor resp